Irritable Bowel Syndrome News

As we enter the fifth year of Healio Gastroenterology and Liver Disease, it is worth looking back at what made us stand out in 2018: the Peer Tested content from online and print as it fared throughout the year.

Healio Gastroenterology and Liver Disease reported live from Advances in IBD 2018 in Orlando, Florida, highlighting the latest research updates as well as interviews with leading researchers and clinicians. Miguel Regueiro, MD, chair of the Department of Gastroenterology, Hepatology and Nutrition at the Cleveland Clinic, speaks with fellows during a breakout session that highlighted life outside of training, including the legal aspects of an IBD practice. James Lindsay, PhD, BM BCh, FRCP, gives a keynote presentation with a European perspective on positioning biosimilars in IBD. Bruce and Cynthia Sherman announce the 2018 recipients of the Sherman Prize for their research in the treatment of Crohn’s disease and ulcerative colitis.

Changes in a patient’s gut microbiota could help clinicians differentiate patients with inflammatory bowel disease and those with irritable bowel syndrome, according to research published in Science Translational Medicine.

Hypnotherapy in both individual and group sessions helped patients with irritable bowel syndrome achieve symptoms relief, according to research published in The Lancet Gastroenterology & Hepatology.

NEWARK, Del. — Many foods can exacerbate symptoms of irritable bowel syndrome, but several randomized clinical trials show benefit of a low FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols) diet, Asyia Ahmad, MD, MPH, chief of gastroenterology at Drexel University College of Medicine, said at the second annual GI Symposium.

PHILADELPHIA — In this exclusive video perspective from the American College of Gastroenterology Annual Meeting, Nicholas Talley, MD, PhD, FACG, from the University of Newcastle in Australia, discusses the changing world of functional gastrointestinal disorders.

PHILADELPHIA – Gemelli Biotech, in cooperation with the Medically Associated Science and Technology Program at Cedars-Sinai, announced the availability of ibs-smart, a blood test for the diagnosis of irritable bowel syndrome, at the close of the American College of Gastroenterology Annual Scientific Meeting.

PHILADELPHIA — In this exclusive video perspective from the American College of Gastroenterology Annual Meeting, Matt Mitcho, CEO of Gemelli Biotech, talks about the company’s new partnership with Cedars-Sinai, IBS Smart.

PHILADELPHIA – Given the vast number and varying kinds of therapies currently available for the treatment of irritable bowel syndrome, choosing the right one comes down to many different factors.

Healio Gastroenterology and Liver Disease has compiled a list of the top five gastroenterology stories posted in September.